Skip to main content

Table 4 Distribution of the studied cases as per SVR

From: Assessment of carotid atherosclerosis in Egyptian chronic hepatitis C patients after treatment by direct-acting antiviral drugs

 

Studied patients

(no. = 80)

No

%

SVR

Nonresponders

3

3.75%

Responders

77

96.25%

  1. Fifty-six (70%) patients were treated by SOF/DAC regimen, while 24 (30%) patients were treated by SOF/DAC/RBV regimen